SCHEMBL32671774

SCHEMBL32671774

O=c1c(=O)c2ccccc2c2ccccc2c2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.48
▸ HSD17B10 Q99714 5/20 0.48
▸ KDM4E B2RXH2 4/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ HPGD P15428 3/20 0.48
▸ LMNA P02545 3/20 0.48
▸ MAPT P10636 3/20 0.48
▸ GAA P10253 3/20 0.48
▸ GLA P06280 2/20 0.48
▸ HTT P42858 2/20 0.48
▸ ATM Q13315 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ PGAM1 P18669 1/20 0.48
▸ MAOA P21397 1/20 0.48
▸ CASP1 P29466 1/20 0.48
▸ CASP7 P55210 1/20 0.48
▸ PAX8 Q06710 1/20 0.46
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL927812 0.96 ALDH1A1 (0.50) ALDH1A1HSD17B10KDM4ESMN1; SMN2HPGD
SCHEMBL6050558 0.92 ALDH1A1 (0.48) ALDH1A1HSD17B10KDM4ESMN1; SMN2HPGD
SCHEMBL29362920 0.92 ALDH1A1 (0.48) ALDH1A1HSD17B10KDM4ESMN1; SMN2HPGD
SCHEMBL17987 0.92 ALDH1A1 (0.48) ALDH1A1HSD17B10KDM4ESMN1; SMN2HPGD
SCHEMBL6369595 0.92 ALDH1A1 (0.55) ALDH1A1HSD17B10KDM4ESMN1; SMN2HPGD
SCHEMBL5536637 0.89 ALDH1A1 (0.46) ALDH1A1HSD17B10KDM4ESMN1; SMN2HPGD
Water SCHEMBL592692 0.89 ALDH1A1 (0.46) ALDH1A1HSD17B10KDM4ESMN1; SMN2HPGD
SCHEMBL4930798 0.89 ALDH1A1 (0.46) ALDH1A1HSD17B10KDM4ESMN1; SMN2HPGD
SCHEMBL4921603 0.89 ALDH1A1 (0.46) ALDH1A1HSD17B10KDM4ESMN1; SMN2HPGD
SCHEMBL30139899 0.89 ALDH1A1 (0.46) ALDH1A1HSD17B10KDM4ESMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260047334-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2026-02-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260047334-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LBR, LDLR, OXER1 ALDH1A1 1883/4885HSD17B10 2824/4885KDM4E 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback